Chemoinformaics analysis of 2,6-Dimethoxybenzoic acid
| Molecular Weight | 182.175 | nRot | 3 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 7 |
| Exact Molecular Weight | 182.058 | nRing | 1 |
| Solubility: LogS | -1.469 | nHRing | 0 |
| Solubility: LogP | 0.999 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 24.9059 |
| nHD | 1 | BPOL | 14.3721 |
| QED | 0.767 |
| Synth | 1.613 |
| Natural Product Likeliness | 0.244 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.007 |
| CACO-2 | -5.015 |
| MDCK | 0.0000118 |
| BBB | 0.712 |
| PPB | 0.421942 |
| VDSS | 0.362 |
| FU | 0.366369 |
| CYP1A2-inh | 0.078 |
| CYP1A2-sub | 0.855 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.128 |
| CYP2c9-inh | 0.059 |
| CYP2c9-sub | 0.357 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.179 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.141 |
| CL | 6.232 |
| T12 | 0.845 |
| hERG | 0.13 |
| Ames | 0.008 |
| ROA | 0.91 |
| SkinSen | 0.096 |
| Carcinogencity | 0.107 |
| EI | 0.965 |
| Respiratory | 0.545 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.864106 |